Volume

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Concomitant medications and circulating tumor cells: friends or foes?

New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers

The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates

Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities

Nano-TRAIL: a promising path to cancer therapy

Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment

Targeting regulated cell death pathways in acute myeloid leukemia

Anti-BCMA novel therapies for multiple myeloma

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Actions for 0 selected articles

Cancer Drug Resistance
ISSN 2578-532X (Online)
Follow Us

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/